These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4218067)

  • 21. The use of plasmapheresis in pregnancy with antenatal prediction of a serious hemolytic disease due to Rh immunization.
    Woytoń J; Partyka T; Gajewska E; Kwoczyńska K; Baranowski H; Narczewska B; Bochenek S; Zukowska B; Róg-Malinowski M; Dzierzkowa-Borodej W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1139-46. PubMed ID: 107917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical aspects in the prevention of antibody formation with anti-D-immunoglobulin].
    Frey P; Hinselmann M; Hindemann P
    Gynaecologia; 1969; 167(5):280-4. PubMed ID: 4184764
    [No Abstract]   [Full Text] [Related]  

  • 24. [The treatment of isoimmunized women in order to prevent hemolytic disease of the newborn].
    Grishchenko II; Shileĭko VA
    Akush Ginekol (Mosk); 1971 Aug; 47(8):8-13. PubMed ID: 4117023
    [No Abstract]   [Full Text] [Related]  

  • 25. [Plasmapheresis in the treatment of Rh isoimmunizations during gravidity (author's transl)].
    Krislo V; Falckráb E
    Cesk Gynekol; 1981 Apr; 46(3):174-7. PubMed ID: 6793246
    [No Abstract]   [Full Text] [Related]  

  • 26. [Our preliminary experience in the field of serum prevention of anti-HDN hemolytic disease of the newborn by means of anti-D immunoglobulins].
    Arrotta U; Cardinale F; Sideri L
    Minerva Ginecol; 1972 Dec; 24(12):619-26. PubMed ID: 4211544
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of treatment of Rh blood group incompatibility with plasmapheresis].
    Woytoń J; Baranowski H; Kwoczyńska K; Partyka T; Dzierzkowa W
    Ginekol Pol; 1979; Suppl():62-4. PubMed ID: 121293
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy and prevention of hemolytic disease of the newborn caused by the Rh factor].
    Kogoj-Bakic V
    Lijec Vjesn; 1970 Nov; 92(11):1323-31. PubMed ID: 4332439
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anti-D prevention. Review and outlook for 1976].
    Schneider J
    Fortschr Med; 1976 Nov; 94(31):1747-52. PubMed ID: 826466
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful management of pregnancy and hemolytic disease of the newborn due to anti-HrO in a woman of the D--phenotype.
    Deitenbeck R; Tutschek B; Crombach G; Stannigel H
    Transfusion; 1999 Oct; 39(10):1151-2. PubMed ID: 10532613
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experience with intensive plasmapheresis in maternal Rh iso-immunization].
    Simon G; Fias I; Domby E; Horváth I
    Orv Hetil; 1982 May; 123(20):1227-33. PubMed ID: 6810255
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunological aspects of the prevention of hemolytic disease of the newborn].
    Antonian AK
    Zh Eksp Klin Med; 1973; 13(6):44-9. PubMed ID: 4215267
    [No Abstract]   [Full Text] [Related]  

  • 33. [Severe erythroblastosis. Prospect of subsequent live births after pregnancy with intrauterine foetal death].
    Klingenberg I
    Tidsskr Nor Laegeforen; 1970 Mar; 90(5):478-81. PubMed ID: 4987610
    [No Abstract]   [Full Text] [Related]  

  • 34. The prevention of Rh-haemolytic disease.
    Clarke CA
    Sci Basis Med Annu Rev; 1968; ():168-85. PubMed ID: 4970016
    [No Abstract]   [Full Text] [Related]  

  • 35. Intensive plasmapheresis during pregnancy and spurious amniotic fluid bilirubin.
    Sussmann LN; Barias M; Colli W
    Am J Obstet Gynecol; 1979 Sep; 135(1):156-7. PubMed ID: 474648
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemolytic disease of the newborn caused by anti-c antibodies. Case report].
    Ornat K; Cyran T; Maszkiewicz W
    Acta Haematol Pol; 1988; 19(1-2):75-6. PubMed ID: 3149114
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anti-c antibodies as a cause of severe form of hemolytic disease of the newborn].
    Sławek Z; Stolarz E; Banaszkiewicz A; Walczak Z; Surowiec E
    Acta Haematol Pol; 1988; 19(1-2):71-4. PubMed ID: 3149113
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 39. [The diagnosis and antenatal prevention of hemolytic disease of the newborn in Rh sensitized women].
    Persianinov LS; Sidel'nikova VM
    Akush Ginekol (Mosk); 1971 Aug; 47(8):3-8. PubMed ID: 4342988
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antenatal treatment of maternal-fetal Rh incompatibility hemolysis disease].
    Zhao L; Huang X; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jul; 33(7):406-8. PubMed ID: 10806699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.